|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/422 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Patento numeris | 3454850 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17796837.7 |
| Europos patento paraiškos padavimo data | 2017-05-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/032151 |
| Data | 2017-05-11 |
| (87) | Numeris | WO 2017/197107 |
| Data | 2017-11-16 |
| (30) | Numeris | Data | Šalis |
| 201662334748 P | 2016-05-11 | US |
| (72) |
LEO, Pavliv , US
MACIAS-PEREZ, Ines , US
WEST, James , US
CARRIER, Erica , US
|
| (73) |
Cumberland Pharmaceuticals Inc. ,
2525 West End Avenue
Suite 950, Nashville, TN 37203,
US
Vanderbilt University , 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US |
| (54) | COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY WITH THROMBOXANE-A2 RECEPTOR ANTAGONISTS |
| COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY WITH THROMBOXANE-A2 RECEPTOR ANTAGONISTS |